Venture Capital

One of Wisconsin's most prominent pharmaceutical companies has been purchased, its stock delisted and its name changed. The move will result in a continued, but perhaps limited, presence in Wisconsin, create potential opportunites for the state's life science industry, increase distribution of their drug and...

Researchers at the Ludwig Institute for Cancer Research, using technology made by Madison-based NimbleGen Systems, have developed a method to identify thousands of regulatory sequences in the human genome....

Madison, Wis. - The June 20 issue of The Scientist, named Madison, "the Midwest's low-key hotspot" for biotechnology. The publication reported that the city's research facilities and open community make it one of the best climates for starting or continuing a biotech and life sciences...

The state Assembly on Thursday passed AB 499, a proposed ban on all forms of human cloning in Wisconsin. Penalties for violating the bill if it becomes law would go up to ten years in prison and $1 million in fines. ...

Howard Anderson, who teaches courses on early-stage companies at the Massachusetts Institute of Technology, founded or co-founded three venture capital funds. He was a self-described “financial samurai.” Now, he’s hanging up his sword, declining to raise new money for his funds....

The two-day event showcased 130 technology companies to an audience of several hundred venture capital, strategic and angel investors. This forum should be of particular interest to Midwest technology entrepreneurs as there were several surprises. Most of them were pleasant, too....